Panagora Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Panagora Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-425	Closed	-$10K	–	2695
2019 Q2	$10K	Sell	425 -289	-40%	-$14K	﹤0.01%	2405
2019 Q1	$49K	Buy	714 +78	+12%	+$5.01K	﹤0.01%	2046
2018 Q4	$34K	Buy	636 +51	+9%	+$3.26K	﹤0.01%	2080
2018 Q3	$40K	Sell	585 -20	-3%	-$1.81K	﹤0.01%	2069
2018 Q2	$72K	Sell	605 -489	-45%	-$49.1K	﹤0.01%	1956
2018 Q1	$91K	Hold	1,094	–	–	﹤0.01%	1880
2017 Q4	$163K	Sell	1,094 -3,209	-75%	-$308K	﹤0.01%	1735
2017 Q3	$267K	Sell	4,303 -1,046	-20%	-$61.4K	﹤0.01%	1565
2017 Q2	$250K	Buy	5,349 +1,268	+31%	+$64.7K	﹤0.01%	1565
2017 Q1	$250K	Buy	4,081 +1,995	+96%	+$116K	﹤0.01%	1586
2016 Q4	$124K	Hold	2,086	–	–	﹤0.01%	1888
2016 Q3	$152K	Sell	2,086 -22	-1%	-$1.7K	﹤0.01%	1851
2016 Q2	$168K	Buy	+2,108	New	+$402K	﹤0.01%	1734
2016 Q1	–	Sell	-45	Closed	-$27K	–	2362
2015 Q4	$27K	Buy	+45	New	+$30.4K	﹤0.01%	2103

Other funds holding SRRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Panagora Asset Management's SRRA Position: Q3 2019 in Review

Panagora Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2019, closing a stake of 425 shares — an estimated $10K sold.

Panagora Asset Management first reported a position in SRRA in Q4 2015 and held it in 14 quarters. The position peaked at $267K in Q3 2017. 45 funds tracked by Wall St. Rank hold SRRA as of Q3 2019.

Panagora Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Panagora Asset Management sold 425 Sierra Oncology, Inc. Common Stock shares in Q3 2019, an estimated $10K.
Panagora Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 14 quarters.
Panagora Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $267K in Q3 2017.
45 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.